NEWS: NOVEMBER 2004

-11/12/2004-

GlaxoSmithKline's vaccine stops human papilloma virus in cervical cancer. To read article click here.

Elan Corporation and Mayo Foundation for Medical Education and Research settle patent suit on Alzheimer's disease research. To read article click here.

-11/11/2004-

Amgen Inc. forms Amgen Ventures. To read article click here.

Merck & Co begins outsourcing drug discovery research to Indian CROs. To read article click here.

-11/10/2004-

Press Release: Tecan, a leading player in the health care supply industry, and Dynal Biotech, a world leader in biomagnetic separation, have announced a non-exclusive licensing agreement to co-develop, promote and market optimised robotic applications based on Dynal Biotech research kits (Dynabeads®) for use on Tecan's new Freedom EVO automated platform. To read press release click here.

Press Release: The Coulochem III electrochemical (EC) detector from ESA is an acknowledged standard for highly sensitive and selective HPLC diagnostic assays including Plasma-free Metanephrines, Urinary Metanephrines, Fractionated Urinary Catecholamines and simultaneous determination of Urinary VMA, 5HIAA and HVA. To read press release click here.

Novartis AG to pay Vertex Pharmaceuticals Inc. $10 million to develop Vertex's VX-322 for cancer treatment. To read article click here.

Dyax Corp. and Biogen Idec Inc. sign agreement for 3-year research collaboration. To read article click here.

Neurocrine Biosciences Inc. and Almirall Prodesfarma sign license agreement on A2A receptor antagonists for Parkinson's disease. To read article click here.

-11/09/2004-

Argonaut Technologies introduces the EVOLUTE ABN (Acidic Basic Neutral) to extract drugs from biological fluids through improved solid phase extraction (SPE). To read article click here.

Insmed Incorporated receives eduropean patent EP1183042 entitled "Methods for Treating Diabetes". To read article click here.

Immtech International Inc. competes Phase IIb clinical trial of DB289 for treating African sleeping sickness. To read article click here.

Genentech Inc. and Rinat Neuroscience to co-develop and commercialize RI 624 for acute and chronic pain. To read article click here.

Pharmacopeia Drug Discovery Inc. achieves milestone in research collaboration with Organon. To read article click here.

Tripos Inc. and NovaScreen Biosciences Corporation form joint collaboration for a cancer drug discovery collaboration with Strida Pharma Inc. To read article click here.

-11/08/2004-

Press Release: Tecan Europe has announced the introduction of LS Reloaded™, a new series of versatile automation-friendly microarray scanners. To read press release click here.

Press Release: The new Cell Cycle assay from Guava Technologies, Inc. makes cell cycle analysis easier than ever before for applications in Immunology, Cancer Drug Discovery and Cell Health Profiling. To read press release click here.

Aventis terminates terminates partnership with Genta Incorporated regarding Genasense®. To read article click here.

Medarex Inc. and Bristol-Myers Squibb Co. form collaboration to develop and market MDX-010 for melanoma treatment. To read article click here.

BioCryst Pharmaceuticals Inc. initiates Phase I clinical trials of purine nucleoside phosphorylase inhibitor BCX-4208 for psoriasis treatment. To read article click here.

-11/05/2004-

FDA approves Sanofi-Synthelabo's Eloxatin for the treatment of colon cancer. To read article click here.

Medicure Inc. receives U.S. patent 6,780,997 entitled "Cardioprotective Phosphonates and Malonates". To read article click here.

-11/04/2004-

Genzyme Corp. to buy back the rights of Synvisc from Wyeth Pharmaceuticals. To read article click here.

Inspire Pharmaceuticals Inc. to license several patents from the Wisconsin Alumni Research Foundation for glaucoma. To read article click here.

-11/03/2004-

Press Release: The Biochemistry-Chemistry-Engineering interface (BiCE) programme has selected Radleys Discovery Technologies to supply parallel chemistry equipment to help speed process selection and investigation of chemistries and biocatalysts in the synthesis of novel molecules to be used in the development of next generation pharmaceuticals. To read press release click here.

Press Release: The aliQuot low-volume liquid dispenser with automated Stacker from Genetix allows for the controlled dispensing of cells. To read press release click here.

ViroPharma Inc. to license experimental treatment for the common cold to Schering-Plough Corp. To read article click here.

-11/02/2004-

FDA grants fast-track status to Millennium Pharmaceuticals Inc.'s Velcade (bortezomib) for relapsed and treatment-resistant mantle cell lymphoma. To read article click here.

Accelrys Inc. and the University of Cambridge extend research software collaboration. To read article click here.

Progenics Pharmaceuticals Inc. and Cytogen Corporation receive NIH $7.4 million grant for prostate cancer immunotherapies. To read article click here.

-11/01/2004-

Nuvelo Inc. to regain rights to anti-clot drug alfimeprase from Amgen Inc. To read article click here.

MedImmune Inc. to initiate Phase 3 clinical trials of Numax for the prevention of the respiratory syncytial virus. To read article click here.

Maxim Pharmaceuticals Inc. to withdraw application to the FDA for regulatory approval of its Ceplene therapy for the treatment of advanced malignant melanoma. To read article click here.